Delivery Order SPE2DB20D1109-SPE2DB23FP25N
Award Date 6/2/23
Potential Completion Date 6/5/23
Potential Value $25K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $10,041.31 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Eliquis 5 mg tablets and has an ultimate completion date of January 21, 2022. This award is under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC enables the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $26,996.52, is for the delivery of Eliquis 5 mg tablets. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,776.16 firm-fixed-price delivery order contract is for the supply of Eliquis 5 mg tablets, a cardiovascular medication. The contract has a period of performance through February 2024. This award is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,356.69 firm fixed-price delivery order contract is for the supply of Eliquis 5 mg tablets. The contract has an ultimate completion date of January 29, 2024 and was awarded on January 26, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $3,576.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Eliquis 5 mg tablets, a pharmaceutical product, with a completion date of February 28, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025....
- This federal contract award, valued at $2,170.87, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Eliquis 5 mg tablets and has an ultimate completion date of April 12, 2023. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025....
- This federal contract award, valued at $23,282.66, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Eliquis 5 mg tablets, a pharmaceutical product used for various medical conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $7,461.99, is for the delivery of Eliquis 5 mg tablets in quantities of 60s. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC enables efficient procurement of a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,237.31, is for the delivery of Eliquis 5 mg tablets. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to...
- This federal contract award is between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. The contract, valued at $14,345.72, is for the delivery of Eliquis 5 mg tablets to support military treatment facilities and federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which serves as...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP25NDelivery Order
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order worth $24,596.70 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Eliquis 5 mg tablets and has a completion date of June 5, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating full and open competition.
Generated 2/27/25, 11:17 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.6k | 6/2/23 |